CSIMarket
 


Casi Pharmaceuticals inc   (CASI)
Other Ticker:  
 

Casi Pharmaceuticals Inc 's Leverage Ratio

CASI's quarterly Leverage Ratio and Total Liabilities, Equity growth




CASI Leverage Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Change -28.75 % -29.39 % -25.03 % 3.63 % -5.38 %
Y / Y Total Liabilities Change 67.01 % 8.23 % 19.12 % 25.57 % 24.81 %
Leverage Ratio MRQ 0.72 0.44 0.41 0.36 0.31
Overall Ranking # # # # #
Seq. Equity Change -7.82 % -10.73 % -11.26 % -2.43 % -8.64 %
Seq. Total Liabilities Change 52.78 % -5.17 % 1.68 % 13.37 % -1 %



Leverage Ratio third quarter 2022 Comment
Due to net new borrowings of 52.78%, Leverage Ratio detoriated to 0.72, above company's average Leverage Ratio.

Within Biotechnology & Pharmaceuticals industry Casi Pharmaceuticals inc achieved lowest Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are CASI Customers?
Leverage Ratio third quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #


Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Casi Pharmaceuticals Inc 's Equity $ 62 Millions Visit CASI's Balance sheet
Casi Pharmaceuticals Inc 's Total Liabilities $ 45 Millions Visit CASI's Balance sheet
Source of CASI's Sales Visit CASI's Sales by Geography


Cumulative Casi Pharmaceuticals Inc 's Leverage Ratio

CASI's Leverage Ratio for the trailling 12 Months

CASI Leverage Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity TTM Growth -28.75 % -29.39 % -25.03 % 3.63 % -5.38 %
Y / Y Total Liabilities TTM Growth 67.01 % 8.23 % 19.12 % 25.57 % 24.81 %
Leverage Ratio TTM 0.47 0.37 0.34 0.3 0.29
Total Ranking TTM # 1224 # 1137 # 1371 # 1266 # 880
Seq. Equity TTM Growth -7.82 % -10.73 % -11.26 % -2.43 % -8.64 %
Seq. Total Liabilities TTM Growth 52.78 % -5.17 % 1.68 % 13.37 % -1 %


TTM Leverage Ratio Comment
On the trailing twelve months basis Due to net new borrowings of 52.78%, Leverage Ratio improved to 0.47, above Casi Pharmaceuticals Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry 134 other companies have achieved lower Leverage Ratio than Casi Pharmaceuticals Inc . While total ranking remained unchanged compare to previous quarter at no. 1224.

Explain Leverage Ratio?
Who are CASI Customers?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 135
Healthcare Sector # 538
Within the Market # 1224


TTM Leverage Ratio Statistics
High Average Low
0.79 0.41 0.05
(Sep 30 2022)   (Dec 31 2018)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2022, within Biotechnology & Pharmaceuticals Industry Leverage RatioSep 30 2022 MRQ Total LiabilitiesSep 30 2022 MRQ Equity
Azz Inc   1.95 $ 1,675.141  Millions$ 859.621  Millions
Adaptimmune Therapeutics Plc  1.93 $ 218.865  Millions$ 113.337  Millions
Pacific Biosciences Of California Inc   1.90 $ 1,192.358  Millions$ 626.591  Millions
Adma Biologics Inc   1.86 $ 187.173  Millions$ 100.385  Millions
Msa Safety Inc  1.83 $ 1,544.874  Millions$ 842.415  Millions
Coherent Corp   1.76 $ 8,821.521  Millions$ 5,009.038  Millions
Windtree Therapeutics Inc  1.74 $ 30.262  Millions$ 17.420  Millions
Reynolds Consumer Products Inc   1.73 $ 3,114.000  Millions$ 1,798.000  Millions
Avantor Inc   1.70 $ 7,793.500  Millions$ 4,591.400  Millions
Zivo Bioscience Inc   1.68 $ 2.555  Millions$ 1.524  Millions
Gilead Sciences Inc   1.60 $ 33,660.000  Millions$ 21,057.000  Millions
Codiak Biosciences Inc   1.54 $ 59.883  Millions$ 38.929  Millions
Meiragtx Holdings Plc  1.46 $ 178.742  Millions$ 122.670  Millions
Cadre Holdings inc   1.37 $ 215.093  Millions$ 156.560  Millions
Akoya Biosciences Inc   1.35 $ 101.369  Millions$ 75.088  Millions
Biocardia Inc  1.24 $ 5.082  Millions$ 4.097  Millions
Educational Development Corporation  1.22 $ 57.088  Millions$ 46.624  Millions
Central Garden and Pet Co  1.20 $ 1,605.032  Millions$ 1,334.712  Millions
Logicbio Therapeutics Inc   1.20 $ 18.816  Millions$ 15.739  Millions
Curis Inc   1.18 $ 66.006  Millions$ 55.745  Millions
Aspira Women s Health Inc   1.14 $ 12.691  Millions$ 11.178  Millions
Pluri Inc   1.09 $ 29.260  Millions$ 26.901  Millions
Harvard Bioscience Inc  1.04 $ 75.034  Millions$ 71.979  Millions
Oncocyte Corporation  1.01 $ 77.552  Millions$ 76.857  Millions
Lsi Industries Inc   1.00 $ 153.910  Millions$ 153.729  Millions
Armata Pharmaceuticals Inc   0.99 $ 45.081  Millions$ 45.577  Millions
Livento Group Inc   0.99 $ 22.118  Millions$ 22.440  Millions
Atara Biotherapeutics Inc   0.97 $ 181.203  Millions$ 187.113  Millions
Biogen Inc   0.95 $ 12,078.700  Millions$ 12,766.800  Millions
Sangamo Therapeutics Inc   0.92 $ 284.759  Millions$ 309.154  Millions

Date modified: 2022-11-16T03:23:24+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

APGR's Profile

Stock Price

APGR's Financials

Business Description

Fundamentals

Charts & Quotes

APGR's News

Suppliers

APGR's Competitors

Customers & Markets

Economic Indicators

APGR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071